The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1
| Autor: | Francisco Gonzalez-Lima, Jack C. de la Torre |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Drug Industry business.industry General Neuroscience MEDLINE General Medicine Disease Antibodies Monoclonal Humanized Raising (linguistics) United States Psychiatry and Mental health Clinical Psychology Alzheimer Disease Medicine Humans Aducanumab Geriatrics and Gerontology business Intensive care medicine Drug Approval |
| Zdroj: | Journal of Alzheimer's disease : JAD. 82(3) |
| ISSN: | 1875-8908 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|